Virtual-Ports Receives CE Certification for Revolutionary Surgical Products

Virtual-Ports Ltd is thrilled to announce the attainment of CE certification under the new MDR (Medical Device Regulation 2017/745) for its groundbreaking surgical products. Renowned for their single-hand, multi-application design, Virtual-Ports’ solutions are set to revolutionize abdominal surgery by significantly improving visibility and access within the surgical space.

At the core of Virtual-Ports’ innovation is its MicroAnchoring™ technology, a proprietary system engineered to empower surgeons with enhanced control and clinical precision during laparoscopic procedures. This advancement not only reduces access ports and reliance on operating room assistance but also eliminates the need for a fourth robotic arm in Robotic-assisted surgery, thus mitigating complications and related costs. The acquisition of CE certification is crucial for commercial product sales in European, UK, and other international markets that recognize CE marks.

CEO Yuval Yaskil of Virtual-Ports Remarked

“Attaining the CE certification under the new MDR requirements not only allows Virtual-Ports to access a long-awaited multi-billion-dollar market, but it is also a testament to the quality and advancement of Virtual-Ports as a company. This milestone underscores our steadfast commitment to empowering surgeons and healthcare systems with cutting-edge solutions that promote safer and more cost-effective clinical outcomes.”

With the CE certification in hand, Virtual-Ports is poised to introduce its transformative technology to medical professionals and patients across Europe, further cementing its position as a leader in the surgical technology landscape.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version